PofoliaShared via Pofolia

Annals of Internal Medicine· 2013Q1

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

Virginia A. Moyer, on behalf of the U.S. Preventive Services Task Force*

Short summary

Annual low-dose CT screening for lung cancer is recommended for adults aged 55-80 with a 30 pack-year smoking history who currently smoke or quit within 15 years.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Annual low-dose CT screening is recommended for lung cancer.
  • Target population: Adults aged 55-80 years.
  • Eligibility criteria: 30 pack-year smoking history, current smoker or quit within 15 years.
  • Screening cessation criteria: 15 years smoke-free, or health issues limiting life expectancy/surgery.

AI-generated from the title and abstract; the full text is not read.

Abstract

DESCRIPTION: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer. METHODS: The USPSTF reviewed the evidence on the efficacy of low-dose computed tomography, chest radiography, and sputum cytologic evaluation for lung cancer screening in asymptomatic persons who are at average or high risk for lung cancer (current or former smokers) and the benefits and harms of these screening tests and of surgical resection of early-stage non-small cell lung cancer. The USPSTF also commissioned modeling studies to provide information about the optimum age at which to begin and end screening, the optimum screening interval, and the relative benefits and harms of different screening strategies. POPULATION: This recommendation applies to asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. RECOMMENDATION: The USPSTF recommends annual screening for lung cancer with low-dose computed tomography in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. (B recommendation).

The authors' abstract, as published at the source. Annals of Internal Medicine, 2013 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Pulmonary and Respiratory Medicine

Pulmonary and Respiratory MedicineMedicine